{"id":14,"date":"2015-06-15T09:16:11","date_gmt":"2015-06-15T07:16:11","guid":{"rendered":"http:\/\/scholar.semmelweis.hu\/bodorc\/?page_id=14"},"modified":"2025-03-17T14:14:25","modified_gmt":"2025-03-17T13:14:25","slug":"kutatas","status":"publish","type":"page","link":"https:\/\/scholar.semmelweis.hu\/bodorc\/kutatas\/","title":{"rendered":"Kutat\u00e1s"},"content":{"rendered":"<p style=\"text-align: justify;\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-511 alignleft\" src=\"http:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2015\/06\/MOK-3-logo-01.jpg\" alt=\"MOK 3 logo-01\" width=\"1337\" height=\"475\" srcset=\"https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2015\/06\/MOK-3-logo-01.jpg 2191w, https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2015\/06\/MOK-3-logo-01-300x107.jpg 300w, https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2015\/06\/MOK-3-logo-01-768x273.jpg 768w, https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2015\/06\/MOK-3-logo-01-1024x364.jpg 1024w\" sizes=\"(max-width: 1337px) 100vw, 1337px\" \/><\/p>\n<p style=\"text-align: justify;\">\u00a0<\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.hcemm.eu\/teams\/genomic-instability-and-cancer\/hcemm-su-molecular-oncohematology-research-group\/\">Kutat\u00e1saink<\/a> k\u00fcl\u00f6nb\u00f6z\u0151 onkohematol\u00f3giai megbeteged\u00e9sek genomikai \u00e9s epigenetikai h\u00e1tter\u00e9nek megismer\u00e9s\u00e9t c\u00e9lozz\u00e1k. A betegs\u00e9gek kialakul\u00e1s\u00e1nak jobb meg\u00e9rt\u00e9s\u00e9n t\u00fal, kutat\u00e1si tev\u00e9kenys\u00e9g\u00fcnkkel \u00faj ter\u00e1pi\u00e1s c\u00e9lpontok \u00e9s a mindennapi molekul\u00e1ris diagnosztik\u00e1ban alkalmazhat\u00f3 \u00fagynevezett biomarkerek azonos\u00edt\u00e1s\u00e1hoz szeretn\u00e9nk hozz\u00e1j\u00e1rulni, jav\u00edtva ez\u00e1ltal az onkohematol\u00f3giai betegek \u00e9letkil\u00e1t\u00e1sait.<\/p>\n<p style=\"text-align: justify;\">Munk\u00e1nkat 2015-2020 k\u00f6z\u00f6tt a Magyar Tudom\u00e1nyos Akad\u00e9mia <a href=\"https:\/\/mta.hu\/lendulet\">Lend\u00fclet<\/a> programja is t\u00e1mogatta.<\/p>\n<p>2021-2026 k\u00f6z\u00f6tt a <a href=\"https:\/\/www.hcemm.eu\/teams\/genomic-instability-and-cancer\/hcemm-su-molecular-oncohematology-research-group\/\"><strong>HCEMM Transzl\u00e1ci\u00f3s Medicina programja<\/strong><\/a> t\u00e1mogatja kutat\u00e1sunkat.<\/p>\n<h4><strong>Kapcsol\u00f3d\u00f3 p\u00e1ly\u00e1zatok<\/strong><\/h4>\n<ul>\n<li style=\"text-align: justify;\">\u2019Epigenetic model of Follicular Lymphoma.\u2019 (Eur\u00f3pai Hematol\u00f3gus T\u00e1rsas\u00e1g (EHA) posztdoktori kutat\u00f3i p\u00e1ly\u00e1zata). Futamid\u0151: 3 \u00e9v (2010-2012). T\u00e1mogat\u00e1si \u00f6sszeg: 90 000 Eur\u00f3.<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>Aberr\u00e1ns epigenetikai szab\u00e1lyoz\u00e1s \u00e9s annak ter\u00e1pi\u00e1s vonatkoz\u00e1sai follicularis lymphom\u00e1ban. (Szent-Gy\u00f6rgyi Albert posztdoktori \u00f6szt\u00f6nd\u00edj). Futamid\u0151: 1 \u00e9v (2013-2014). T\u00e1mogat\u00e1si \u00f6sszeg: 6 milli\u00f3 Forint.<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>Famili\u00e1ris myelodysplasias szindr\u00f3m\u00e1k (MDS) \u00e9s akut myeloid leuk\u00e9mi\u00e1k (AML) genetikai h\u00e1tter\u00e9nek vizsg\u00e1lata. (OTKA-PD p\u00e1ly\u00e1zat). Futamid\u0151: 2 \u00e9v (2013-2015). T\u00e1mogat\u00e1si \u00f6sszeg: 8 milli\u00f3 Forint.<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>Szem\u00e9lyre szabott daganat-ter\u00e1pia: B-sejtes lymphom\u00e1k epigenetikai h\u00e1tter\u00e9nek vizsg\u00e1lata (MTA Lend\u00fclet p\u00e1ly\u00e1zat, MTA-SE Molekul\u00e1ris Onkohematol\u00f3gia Kutat\u00f3csoport) Futamid\u0151: 5 \u00e9v (2015-2020). T\u00e1mogat\u00e1si \u00f6sszeg: 100 milli\u00f3 Forint.<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>\u00daj ter\u00e1pi\u00e1s c\u00e9lpontok azonos\u00edt\u00e1sa \u00e9s nyomonk\u00f6vet\u00e9se folyad\u00e9kbiopszi\u00e1s mint\u00e1kb\u00f3l B-sejtes limf\u00f3m\u00e1kban. (NKFIH_KH17 p\u00e1ly\u00e1zat. Futamid\u0151: 2 \u00e9v (2017-2019). T\u00e1mogat\u00e1si \u00f6sszeg: 19,2 milli\u00f3 Forint.<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>Kr\u00f3nikus Myeloid Leuk\u00e9mia (CML) Ter\u00e1pia Asszisztens &#8211; CTA; A c\u00e9lzott ter\u00e1pia hat\u00e9konys\u00e1g\u00e1nak \u00e9rt\u00e9kel\u00e9s\u00e9t seg\u00edt\u0151 online rendszer kidolgoz\u00e1sa. (Semmelweis Egyetem Innov\u00e1ci\u00f3s p\u00e1ly\u00e1zata) (2018-2019). T\u00e1mogat\u00e1si \u00f6sszeg: 10 milli\u00f3 Forint.<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>ERA-PERMED Human disease modelling of GATA2-related Myelodysplastic Syndromes and Acute Myeloid Leukemia nemzetk\u00f6zi konzorci\u00e1lis p\u00e1ly\u00e1zat (2019-2022). T\u00e1mogat\u00e1si \u00f6sszeg: 1 milli\u00f3 eur\u00f3, BCS kutat\u00f3csoportj\u00e1nak r\u00e9sze: 200 ezer Eur\u00f3.<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>A follikul\u00e1ris limf\u00f3ma t\u00e9rbeli heterogenit\u00e1s\u00e1nak \u00e9s klon\u00e1lis evol\u00faci\u00f3j\u00e1nak vizsg\u00e1lata folyad\u00e9k-biopszi\u00e1s mint\u00e1kon \u00fajgener\u00e1ci\u00f3s szekven\u00e1l\u00e1ssal (Semmelweis Egyetem Innov\u00e1ci\u00f3s p\u00e1ly\u00e1zata) (2020-2021). T\u00e1mogat\u00e1si \u00f6sszeg: 10 milli\u00f3 Forint.<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>Liquid biopsy based genomic profiling and minimal residual disease detection in mature B-cell lymphomas HCEMM Translational Research Group leader p\u00e1ly\u00e1zat (2021-2026): 125 milli\u00f3 Ft<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align: justify;\">Genetic classification and precision medicine in diffuse large B-cell lymphoma. NKFIH_K21 p\u00e1ly\u00e1zat, 2021-2025, 48 milli\u00f3 Ft.<\/li>\n<\/ul>\n<h4><strong>Nemzetk\u00f6zi egy\u00fcttm\u0171k\u00f6d\u00e9sek<\/strong><\/h4>\n<ul style=\"list-style-type: disc;\">\n<li>Prof Jude Fitzgibbon: <a href=\"http:\/\/www.bci.qmul.ac.uk\/\">Barts Cancer Institute<\/a>, London, UK<\/li>\n<li>Dr. Christoph Bock: <a href=\"http:\/\/cemm.at\/\">CeMM<\/a>, B\u00e9cs, Ausztria<\/li>\n<li>Dr. Robert Kralovics: <a href=\"http:\/\/cemm.at\/\">CeMM<\/a>, B\u00e9cs, Ausztria<\/li>\n<li><a href=\"https:\/\/www.mlpa.com\/WebForms\/WebFormMain.aspx?Tag=_fNPBLedDVp38p-CxU2h0mQ..\">MRC Holland<\/a>, Amsterdam, Hollandia<\/li>\n<li><a href=\"http:\/\/www.nanostring.com\/\">Nanostring<\/a>, Seattle, USA<\/li>\n<\/ul>\n<h4><strong>A kutat\u00f3csoport tagjai<\/strong><\/h4>\n<ul>\n<li><a href=\"http:\/\/scholar.semmelweis.hu\/bodorc\/cv\/\">Dr. B\u00f6d\u00f6r Csaba<\/a>, csoportvezet\u0151<\/li>\n<li><a href=\"https:\/\/scholar.semmelweis.hu\/alpardonat\/\">Dr. Alp\u00e1r Don\u00e1t<\/a>, posztdoktor kutat\u00f3<\/li>\n<li><a href=\"https:\/\/scholar.semmelweis.hu\/matolcsya\/\">Prof. Dr. Matolcsy Andr\u00e1s<\/a>, egyetemi tan\u00e1r, tan\u00e1csad\u00f3<\/li>\n<li><a href=\"http:\/\/scholar.semmelweis.hu\/bodorc\/phd-hallgatok\/\">Dr. Nagy No\u00e9mi<\/a>, tudom\u00e1nyos munkat\u00e1rs<\/li>\n<li><a href=\"http:\/\/scholar.semmelweis.hu\/bodorc\/tdk-tevekenyseg\/#jp-carousel-207\">Dr. Kiss Rich\u00e1rd<\/a>, rezidens orvos<\/li>\n<li><a href=\"http:\/\/scholar.semmelweis.hu\/bodorc\/phd-hallgatok\/\">Dr. Nagy \u00c1kos<\/a>, PhD hallgat\u00f3<\/li>\n<li><a href=\"http:\/\/scholar.semmelweis.hu\/bodorc\/phd-hallgatok\/\">Dr. Krizs\u00e1n Szilvia<\/a>, PhD hallgat\u00f3<\/li>\n<li><a href=\"http:\/\/scholar.semmelweis.hu\/bodorc\/phd-hallgatok\/\">Dr. Bedics G\u00e1bor<\/a>, PhD hallgat\u00f3<\/li>\n<li><a href=\"https:\/\/scholar.semmelweis.hu\/bodorc\/phd-hallgatok\/?preview_id=419&amp;preview_nonce=9e0f4554f5&amp;_thumbnail_id=-1&amp;preview=true\">B\u00e1tai Bence<\/a>, MD-PhD hallgat\u00f3<\/li>\n<li><a href=\"https:\/\/scholar.semmelweis.hu\/bodorc\/phd-hallgatok\/?preview_id=419&amp;preview_nonce=9e0f4554f5&amp;_thumbnail_id=-1&amp;preview=true\">Kotmayer Lili<\/a>, MD-PhD hallgat\u00f3<\/li>\n<li>Hegyi Lajos, biotechnol\u00f3gus<\/li>\n<li>Kiss Laura, TDK hallgat\u00f3<\/li>\n<\/ul>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1186 size-large aligncenter\" src=\"https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2022\/10\/Team-2022-1024x683.jpg\" alt=\"\" width=\"753\" height=\"502\" srcset=\"https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2022\/10\/Team-2022-1024x683.jpg 1024w, https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2022\/10\/Team-2022-300x200.jpg 300w, https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2022\/10\/Team-2022-768x512.jpg 768w, https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2022\/10\/Team-2022-1536x1024.jpg 1536w, https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2022\/10\/Team-2022-2048x1365.jpg 2048w, https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2022\/10\/Team-2022-753x502.jpg 753w, https:\/\/scholar.semmelweis.hu\/bodorc\/wp-content\/uploads\/sites\/40\/2022\/10\/Team-2022-203x135.jpg 203w\" sizes=\"(max-width: 753px) 100vw, 753px\" \/><\/p>\n<h6 style=\"text-align: center;\"><em>A HCEMM-SE Lend\u00fclet Molekul\u00e1ris Onkohematol\u00f3gia Kutat\u00f3csoport tagjai<\/em><\/p>\n<\/h6>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 <a href=\"https:\/\/www.hcemm.eu\/teams\/genomic-instability-and-cancer\/hcemm-su-molecular-oncohematology-research-group\/\">Kutat\u00e1saink<\/a> k\u00fcl\u00f6nb\u00f6z\u0151 onkohematol\u00f3giai megbeteged\u00e9sek genomikai \u00e9s epigenetikai h\u00e1tter\u00e9nek megismer\u00e9s\u00e9t c\u00e9lozz\u00e1k. A betegs\u00e9gek kialakul\u00e1s\u00e1nak jobb meg\u00e9rt\u00e9s\u00e9n t\u00fal, kutat\u00e1si tev\u00e9kenys\u00e9g\u00fcnkkel \u00faj ter\u00e1pi\u00e1s c\u00e9lpontok \u00e9s a mindennapi molekul\u00e1ris diagnosztik\u00e1ban alkalmazhat\u00f3 \u00fagynevezett biomarkerek azonos\u00edt\u00e1s\u00e1hoz szeretn\u00e9nk hozz\u00e1j\u00e1rulni, jav\u00edtva ez\u00e1ltal az &hellip;<\/p>\n","protected":false},"author":36,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"footnotes":""},"class_list":["post-14","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/scholar.semmelweis.hu\/bodorc\/wp-json\/wp\/v2\/pages\/14"}],"collection":[{"href":"https:\/\/scholar.semmelweis.hu\/bodorc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/scholar.semmelweis.hu\/bodorc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/scholar.semmelweis.hu\/bodorc\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/scholar.semmelweis.hu\/bodorc\/wp-json\/wp\/v2\/comments?post=14"}],"version-history":[{"count":58,"href":"https:\/\/scholar.semmelweis.hu\/bodorc\/wp-json\/wp\/v2\/pages\/14\/revisions"}],"predecessor-version":[{"id":1241,"href":"https:\/\/scholar.semmelweis.hu\/bodorc\/wp-json\/wp\/v2\/pages\/14\/revisions\/1241"}],"wp:attachment":[{"href":"https:\/\/scholar.semmelweis.hu\/bodorc\/wp-json\/wp\/v2\/media?parent=14"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}